The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.
Targeted neuromodulation may be a future method to help those with severe, untreatable depression - traditionally, this is used to correct misfiring brain circuits in people with epilepsy or Parkinson's.
We reflect on the work of the Molecular and Cellular Biosciences division (MCB), especially in context of the “complex biological web” of a global pandemic.
South Asians have the highest rate of type 2 diabetes in the UK, due to a mix of racial and socioeconomic factors - now, researchers say that a more nuanced method of classifying race could improve their health outcomes.
In this interview, Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, considers the possibilities concerning reconstructive dentistry and in this vein, digital technologies.
With 7.5 million people living with HIV, how has climate change and COVID-19 affected the South African governments control over the AIDS crisis and which demographics have been hit the hardest?
Annabelle Neame, Director of Business Development, HCA UK Concierge Centre, looks at the rise of concierge healthcare during the COVID-19 pandemic and whether it is worth the investment.
Here, we learn how international diagnostics group Novacyt are leading the innovation revolution in clinical diagnostics through discovery, design, and innovation.
With a changing climate, animal, insect, and plant species will either adapt or die under new environmental and climate conditions - this brings new challenges in the study of vector-borne infectious diseases.
Despite societal progression and increased LGBTQ+ acceptance, the transgender population still have to jump through hoops to receive healthcare in the UK.
